Karvy
Margins decline due to lower domestic revenues and price impact on key products: Cadila's revenues increased by 15.3% on a YoY basis to Rs 37.3 bn (our estimate of Rs 38.1 bn) during the quarter.
Zydus Lifesciences L.. has an average target of 1045.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended